Pathstone Family Office’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.89M Buy
54,108
+26,161
+94% +$1.96M 0.03% 325
2023
Q2
$2.2M Sell
27,947
-1,203
-4% -$93.1K 0.03% 302
2023
Q1
$2.22M Sell
29,150
-43,918
-60% -$3.27M 0.04% 270
2022
Q4
$5.99M Buy
73,068
+3,990
+6% +$299K 0.05% 250
2022
Q3
$4.94M Buy
69,078
+43,238
+167% +$3.39M 0.04% 236
2022
Q2
$2.07M Buy
25,840
+4,942
+24% +$386K 0.05% 210
2022
Q1
$1.63M Buy
20,898
+5,607
+37% +$444K 0.04% 209
2021
Q4
$1.3M Buy
15,291
+4,331
+40% +$338K 0.03% 270
2021
Q3
$828K Buy
10,960
+1,615
+17% +$128K 0.02% 350
2021
Q2
$760K Buy
9,345
+2,078
+29% +$170K 0.02% 343
2021
Q1
$573K Buy
7,267
+4,381
+152% +$343K 0.02% 317
2020
Q4
$247K Buy
2,886
+2,755
+2,103% +$228K 0.01% 233
2020
Q3
$10K Hold
131
﹤0.01% 592
2020
Q2
$10K Sell
131
-616
-82% -$43.8K ﹤0.01% 511
2020
Q1
$50K Hold
747
0.01% 311
2019
Q4
$514K Hold
747
0.01% 291
2019
Q3
$55K Hold
747
0.01% 260
2019
Q2
$54K Buy
+747
New +$53K 0.01% 317
2018
Q3
Sell
-150
Closed -$10K 238
2018
Q2
$10K Buy
150
+1
+0.7% +$65 0.01% 120
2018
Q1
$11K Buy
+149
New +$10.7K 0.01% 214
2017
Q2
Sell
-23
Closed -$2K 430
2017
Q1
$2K Buy
+23
New +$1.61K ﹤0.01% 373
2014
Q2
Sell
-960
Closed -$62K 141
2014
Q1
$62K Hold
960
0.16% 30
2013
Q4
$63K Sell
960
-35
-4% -$2.24K 0.14% 38
2013
Q3
$59K Buy
995
+35
+4% +$2.07K 0.26% 63
2013
Q2
$55K Buy
+960
New +$57K 0.06% 96

Other funds holding CL

Pathstone Family Office's CL Position: Q3 2023 in Review

Pathstone Family Office increased its Colgate-Palmolive (CL) stake by 94% in Q3 2023, buying an estimated $1.96M and bringing the position to 54,108 shares worth $3.89M. The position accounts for 0.03% of the portfolio, ranked #325.

Pathstone Family Office first reported a position in CL in Q2 2013 and has held it in 25 quarters since. The position peaked at $5.99M in Q4 2022. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Pathstone Family Office held 54,108 shares of Colgate-Palmolive worth $3.89M as of Q3 2023.
  • Pathstone Family Office bought 26,161 Colgate-Palmolive shares in Q3 2023, an estimated $1.96M.
  • Colgate-Palmolive made up 0.03% of Pathstone Family Office's portfolio in Q3 2023, its #325 holding.
  • Pathstone Family Office first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 25 quarters since.
  • Pathstone Family Office's Colgate-Palmolive position peaked at $5.99M in Q4 2022.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.